Thanks Enjay. This is good news. I seem to recall some discussion regarding Patterson attempting to patent Leronlimab's MOA without giving Cytodyn credit for it. Does this joint patent mean they agreed to collaborate or has Patterson discontinued his app for the individual patent? Is this that same patent and was it modified to include them? Or was that just a rumor? Could someone more knowledgeable speak to this? Thanks so much.